Yingjun Chang

32PUBLICATIONS
39CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 11, 2026
Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia.

|Mar 21, 2026
Is sex chromosome loss a predictive marker for outcome after sex-mismatched allogeneic hematopoietic stem cell transplantation?

Lu Gao, Na Li, Lin Feng

|Mar 12, 2026
Co-Mutation of ASXL1 and KRAS Defines a Novel Ultra-Adverse-Risk Subtype of Acute Myeloid Leukemia in a Large-Scale Cohort.

Yijing Zhao, Ting Zhao, Feifei Tang

|Aug 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study.

Si-Qi Li, Lan-Ping Xu, Yu Wang

|Aug 21, 2025
Eradicating measurable residual disease via immunotherapy to cure acute lymphoblastic leukemia: current status and future directions.

Xiao-Su Zhao, Yu-Lun Chen, Si-Qi Li

|Jul 02, 2025
Predictive strategies for poor outcomes after allotransplantation in patients with acute myeloid leukemia: what are the options and when should clinicians use them?

Xiao-Su Zhao, Ying-Jun Chang

Pageof 6

Frequent Collaborators

14 joint publications

Yu Wang

14 joint publications

Xiaojun Huang

12 joint publications

Xiaohui Zhang

10 joint publications

Xiaodong Mo